why choose us

First received: August 24, 2023

Clinical Trial: A Relative Bioavailability Study With a Novel PanCytoVir™ Oral Suspension (100 mg/ml)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Relative Bioavailability

Study Type: INTERVENTIONAL


Official Title: A Single Dose Oral Bioavailability Study of PanCytoVir™ Oral Suspension (100 mg/ml) 1000 mg Versus Probenecid 500 mg Tablets, 1000 mg (2 X 500 mg) in Healthy, Adult, Human Subjects Under Fasting

Brief Summary: An open-label, balanced, randomized, two-treatment, two-sequence, two-period, crossover, single dose oral relative bioavailability study of a novel PanCytoVir™ oral suspension (100 mg/mL) versus probenecid 500 mg tablets in normal healthy, adult, human subjects under fasting conditions.

Read more